槐耳多糖调节SPHK1/S1P/S1PR3信号通路对宫颈癌细胞恶性生物学行为的影响

被引:0
|
作者
李丽品
马素艳
安入征
机构
[1] 河北省石家庄市平安医院肿瘤科
关键词
槐耳多糖; SPHK1/S1P/S1PR3信号通路; 宫颈癌; 恶性生物学行为;
D O I
暂无
中图分类号
R285 [中药药理学];
学科分类号
摘要
目的:探究槐耳多糖(HP)调节SPHK1/S1P/S1PR3信号通路对宫颈癌细胞恶性生物学行为的影响。方法:MTT检测槐耳多糖(0、25、50、100、200、400μg/mL)处理的宫颈癌细胞活力,筛选最佳药物浓度。实验分为对照组(Control组)、槐耳多糖低、中、高浓度组(HP-L、HP-M、HP-H组)和槐耳多糖高浓度+SphK1激活剂K6PC-5组(HP-H+K6PC-5组),观察细胞增殖、迁移和侵袭情况;western blot检测SPHK1、S1P、S1PR3、Snail、N-cadherin、E-cadherin蛋白水平。结果:处理24、48、72h后,与0μg/mL比较,50μg/mL、100μg/mL、200μg/mL和400μg/mL的HP处理的细胞活力显著降低(P<0.05)。HP-L组、HP-M组和HP-H组细胞Edu阳性率、侵袭细胞数、划痕愈合率及Snail、N-cadherin、SPHK1、S1P、S1PR3水平显著低于Control组(P<0.05),E-cadherin水平显著升高(P<0.05)。HP-H+K6PC-5组细胞Edu阳性率、侵袭细胞数、划痕愈合率及Snail、N-cadherin、SPHK1、S1P、S1PR3水平显著高于HP-H组(P<0.05),E-cadherin水平显著降低(P<0.05)。结论:HP可能通过抑制SPHK1/S1P/S1PR3信号通路抑制宫颈癌细胞的增殖、侵袭和迁移。
引用
收藏
页码:411 / 416
页数:6
相关论文
共 14 条
  • [1] 槐耳多糖通过抑制AKT/GSK3β/Snail信号通路抑制胰腺癌细胞增殖和上皮间质转化
    雷蕾
    高彦茹
    蔡洲
    黎七雄
    饶小龙
    [J]. 现代肿瘤医学, 2023, 31 (24) : 4536 - 4541
  • [2] 槐耳多糖抑制AEG-1表达对子宫内膜癌细胞生物学行为的影响.[J].张泽敏;庞岚;.川北医学院学报.2023, 10
  • [3] Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM)
    Li, Fei
    Zhang, Yifan
    Lin, Zhoujun
    Yan, Lizhong
    Liu, Qiao
    Li, Yin
    Pei, Xiaolin
    Feng, Ya
    Han, Xiao
    Yang, Juan
    Zheng, Fangxu
    Li, Tianjiao
    Zhang, Yupeng
    Fu, Zhenkun
    Shao, Di
    Yu, Jane
    Li, Chenggang
    [J]. CELL DEATH & DISEASE, 2022, 13 (12)
  • [4] Pathogenic Role of the Sphingosine 1-Phosphate (S1P) Pathway in Common Gynecologic Disorders (GDs): A Possible Novel Therapeutic Target
    Di Paolo, Alice
    Vignini, Arianna
    Alia, Sonila
    Membrino, Valentina
    Delli Carpini, Giovanni
    Giannella, Luca
    Ciavattini, Andrea
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [5] ROS generation attenuates the anti-cancer effect of CPX on cervical cancer cells by inducing autophagy and inhibiting glycophagy..[J].Fan Hui;He Yujia;Xiang Junqi;Zhou Jing;Wan Xinyan;You Jiawei;Du Kailong;Li Yue;Cui Lin;Wang Yitao;Zhang Chundong;Bu Youquan;Lei Yunlong.Redox biology.2022,
  • [6] Phytocompounds from the Medicinal and Dietary Plants: Multi-target Agents for Cervical Cancer Prevention and Therapy
    Shoaib, Shoaib
    Islam, Najmul
    Yusuf, Nabiha
    [J]. CURRENT MEDICINAL CHEMISTRY, 2022, 29 (26) : 4481 - 4506
  • [7] The sphingosine kinase inhibitor SKI-V suppresses cervical cancer cell growth
    Zhang, Yan
    Cheng, Long
    Shi, Xin
    Song, Yu
    Chen, Xiao-yu
    Chen, Min-bin
    Yao, Jin
    Zhang, Zhi-qing
    Cai, Shang
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (07): : 2994 - 3005
  • [8] CMTM6 promotes migration, invasion, and EMT by interacting with and stabilizing vimentin in hepatocellular carcinoma cells
    Huang, Xiaoting
    Xiang, Leyang
    Wang, Baiyao
    Hu, Jijie
    Liu, Chunshan
    Ren, Anbang
    Du, Kunpeng
    Ye, Gengtai
    Liang, Yingying
    Tang, Yunqiang
    Yang, Dinghua
    Yuan, Yawei
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [9] Relationship between Sphk1/S1P and microRNAs in human cancers..[J].Khoei Saeideh Gholamzadeh;Sadeghi Hamid;Samadi Pouria;Najafi Rezvan;Saidijam Massoud.Biotechnology and applied biochemistry.2020, 2
  • [10] Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.[J].Olga A. Sukocheva;Hideki Furuya;Mei Li Ng;Markus Friedemann;Mario Menschikowski;Vadim V. Tarasov;Vladimir N. Chubarev;Sergey G. Klochkov;Margarita E. Neganova;Arduino A. Mangoni;Gjumrakch Aliev;Anupam Bishayee.Pharmacology and Therapeutics.2020,